KWALITY PHARMACEUTICALS
Back to Balance Sheet
|
KWALITY PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹81 Cr | ₹88 Cr | ₹28 Cr | ₹21 Cr | ₹15 Cr |
What is the latest Net Current Assets ratio of KWALITY PHARMACEUTICALS ?
Year | Net Current Assets |
---|---|
Mar2023 | ₹81 Cr |
Mar2022 | ₹88 Cr |
Mar2021 | ₹28 Cr |
Mar2020 | ₹21 Cr |
Mar2019 | ₹15 Cr |
How is Net Current Assets of KWALITY PHARMACEUTICALS Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2023 | ₹81 Cr | -8.01 | |
Mar2022 | ₹88 Cr | 219.94 | |
Mar2021 | ₹28 Cr | 29.75 | |
Mar2020 | ₹21 Cr | 46.51 | |
Mar2019 | ₹15 Cr | - |
Compare Net Current Assets of peers of KWALITY PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KWALITY PHARMACEUTICALS | ₹528.7 Cr | 0.7% | 12.7% | 59.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹368,598.0 Cr | 2% | -0.3% | 59.8% | Stock Analytics | |
CIPLA | ₹114,654.0 Cr | 6% | 2.8% | 50.4% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,348.0 Cr | 3.7% | 5.8% | 17.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,499.0 Cr | 2.6% | 7.9% | 94.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,429.4 Cr | -1.3% | -2.8% | 31.5% | Stock Analytics |
KWALITY PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KWALITY PHARMACEUTICALS | 0.7% |
12.7% |
59.4% |
SENSEX | 1.7% |
-0.8% |
19% |
You may also like the below Video Courses